SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-019969
Filing Date
2019-04-04
Accepted
2019-04-04 16:46:25
Documents
8
Period of Report
2019-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-7838_18k.htm 8-K 47733
2 EX-2.1 a19-7838_1ex2d1.htm EX-2.1 509556
3 EX-10.1 a19-7838_1ex10d1.htm EX-10.1 354649
4 EX-10.2 a19-7838_1ex10d2.htm EX-10.2 271708
5 EX-10.3 a19-7838_1ex10d3.htm EX-10.3 62175
6 EX-99.1 a19-7838_1ex99d1.htm EX-99.1 34931
7 EX-99.2 a19-7838_1ex99d2.htm EX-99.2 369804
8 GRAPHIC g78381mmi001.jpg GRAPHIC 4713
  Complete submission text file 0001104659-19-019969.txt   1658559
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 19732690
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences